Vasa Denticity Ltd
Vasa Denticity Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹86Cr
- +18.3% YoY
- Net profit
- ₹5Cr
- +4.2% YoY
- Margin
- 8.22%
- −0.1 pp YoY
Guidance rank: #8 of 13 in Healthcare Equipment & Supplies
See the sector's top 10 — free with your mobile number.
Vasa Denticity Ltd Q2 FY27 key numbers
- Revenue
- Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs.
As stated in Vasa Denticity Ltd's Q2 FY27 results statement · published 7 Nov 2026. Reported figures, not investment advice.
Based on Vasa Denticity Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs. Quarterly EBITDA: Rs. 639.10 Lacs for Q2 FY 2026 (vs.
From Vasa Denticity Ltd's Q2 FY27 earnings-call transcript · updated 7 Nov 2026.
How did Vasa Denticity's revenue grow in the September 2026 quarter?
What happened to Vasa Denticity's margins in Q2 FY27?
See what Vasa Denticity Ltd said on profitability & margins — free account, 30 seconds.
What capex is Vasa Denticity planning?
See what Vasa Denticity Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Vasa Denticity raising money or cutting debt?
See what Vasa Denticity Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Vasa Denticity's order book?
See what Vasa Denticity Ltd said on order book & pipeline — free account, 30 seconds.
Vasa Denticity Ltd — Quarterly revenue & net profit
Vasa Denticity Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 86 | 73 | +18.3% | 82 | +4.7% |
| Operating profit (EBITDA) | 7 | 6 | +16.5% | 5 | +39.2% |
| Operating margin | 8.22% | 8.35% | -0.1 pp | 6.18% | +2 pp |
| Profit before tax | 7 | 6 | +8.8% | 5 | +30.9% |
| Net profit (PAT) | 5 | 5 | +4.2% | 4 | +24.1% |
| EPS (₹) | 2.97 | 2.88 | +3.1% | 2.40 | +23.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹86 Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vasa Denticity's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Vaidya Sane (Q2 FY27)
Year-on-year (YoY) change: +23% (from INR 687 Lakhs in Sep 2025) . Key results statement takeaways from Vaidya Sane Ayurved Laboratories Ltd's Q2 FY27 results s
- Sahajanand Medi (Q2 FY27)
Slight seasonality in revenue with H2 being marginally higher (~52%) than H1 (~48%). Key concall takeaways from Sahajanand Medical Technologies Ltd's Q2 FY27…
- Molbio Diagnosti (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹259.0 Cr vs ₹580.3 Cr in Q2 FY26 (significant decrease due to rate contract negotiations). Key investor presentation takeaways
- Poly Medicure (Q2 FY27)
Q2 FY27 consolidated revenue from operations: Rs 580.5 Cr, up 30.8% YoY (Q2 FY26: Rs 443.9 Cr). Key investor presentation takeaways from Poly Medicure Ltd's Q2
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Molbio DiagnostiGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vasa Denticity Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vasa Denticity Ltd Q2 FY27 results?
Revenue from Operations for the quarter ended September 30, 2026: Rs. 17,023.64 Lacs. Quarterly EBITDA: Rs. 639.10 Lacs for Q2 FY 2026 (vs.
What is Vasa Denticity Ltd share price analysis?
Vasa Denticity Ltd currently shows a neutral. The stock trades at a P/E of 64.1 with a market cap of ₹775 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Vasa Denticity Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
